PUT - SPRINTER OPEN END - AMGEN | Delayed Deutsche Boerse AG 18:44:39 28/05/2024 BST | ||
| 8 EUR | +12.20% |
|
| Current month | -24.67% | ||
| 1 month | -26.94% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 28/05/24 | 8 | +12.20% |
| 27/05/24 | 7.13 | -2.33% |
| 24/05/24 | 7.3 | +2.24% |
| 23/05/24 | 7.14 | +6.57% |
| 22/05/24 | 6.7 | -0.89% |
Delayed Quote Deutsche Boerse AG
Last update May 28, 2024 at 06:44 pm
More quotesStatic data
| Product type | Certificat Turbo |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | 
Vontobel
|
| WKN | VM9RJ2 |
| ISIN | DE000VM9RJ23 |
| Date issued | 05/02/2024 |
| Strike | 385.1 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 6.28 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 11.77 € |
|---|---|
| Lowest since issue | 5.76 € |
| Spread | 0.28 € |
| Spread % | 3.43% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
300.2
USD
Average target price
316.3
USD
Spread / Average Target
+5.36%
- Stock Market
- Certificates
- Certificat
